ISTH 2026

Medical Materials

Agenda

Coming soon

11:00 AM

Duration 15mins Paris, France

Major surgeries in People with Hemophilia A under NXT007 prophylaxis: Experience from NXTAGE Phase I/II Study

Nogami K, Ogiwara K, Shimonishi N, Nakajima Y, Osuna M, Mizuno N, Kamei Y, Kobayashi R, Shima M, Chen YC

Haematology | Hemophilia A

Add to calendar

Duration 15mins Paris, France

NXT007 prophylaxis in people with hemophilia A with or without factor VIII inhibitors: Combined analysis of two Phase I/II multiple-ascending-dose studies

Mancuso ME, Shima M, Staber JM, Chen YC, López-Jaime FJ, Shen MC, Ventriglia G, Takeyama M, Schmitt C, Park YS, Kiialainen A, Mizuno N, Niggli M, Miyake T, Matino D, Saito T, Jiménez-Yuste V, Kobayashi R, Hart D, Nogami K

Haematology | Hemophilia A

Add to calendar

10:15 AM

Duration 75mins Paris, France

Starting Strong, Staying Strong: Evidence for Sustained Protection for a Life with Haemophilia A

Angela Weyand, Matteo Di Minno, Sébastien Lobet, Christoph Königs

Haematology | Hemophilia A

Add to calendar

11:45 AM

Duration 60mins Paris, France

Assessment of the Bleeding Phenotype Normality in People with Hemophilia A Treated with NXT007 Prophylaxis: Analysis of All-Bleed Data Comparing with Healthy Volunteers within the NXTAGE Study

Shima M, Miwa T, Kojima K, Iwasaki K, Yoneyama K, Sambe T

Haematology | Hemophilia A

Add to calendar

Duration 60mins Paris, France

Indirect treatment comparison of emicizumab versus efanesoctocog alfa prophylaxis in pediatric people with severe hemophilia A

Al-Adwan M, Niggli M, Tobaruela G

Haematology | Hemophilia A

Add to calendar

Duration 60mins Paris, France

Reasons for treatment preference in people with hemophilia A switching from factor VIII prophylaxis to emicizumab in the BEYOND ABR study: A detailed analysis

Kruse-Jarres R, Castaman G, Di Minno MND, Stephensen D, Lobet S, Barlera S, Brocchieri C, Jiménez-Yuste V

Haematology | Hemophilia A

Add to calendar

Duration 60mins Paris, France

Mental and emotional impact of emicizumab treatment in people with hemophilia A: Post hoc analysis of the HAVEN 3 and 4 Studies

Skinner MW, Lee L, Lim E, Tzeng E, Gao L, Buckner TW

Haematology | Hemophilia A

Add to calendar

11:45 AM

Duration 60mins Paris, France

AOZORA: safety and joint health outcomes over 6 years in children with hemophilia A – preliminary report from an early cohort

Shima M, Takedani H, Kitsukawa K, Taki M, Ishiguro A, Nagae C, Nagao A, Ioka A, Hoshiba M, Sugawara Y, Iwasaki K, Nogami K

Haematology | Hemophilia A

Add to calendar

External site

ISTH 2026